Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Meropenem
Drug ID BADD_D01393
Description Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death. In August 2017, a combination antibacterial therapy under the market name vabomere was approved for treatment of adult patients with complicated urinary tract infections (cUTI). Vabomere consists of meropenem and [DB12107] and is intravenously admininstered. The treatment aims to resolve infection-related symptoms and achieve negative urine culture, where the infections are proven or strongly suspected to be caused by susceptible bacteria.
Indications and Usage For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis.
Marketing Status Prescription; Discontinued
ATC Code J01DH02
DrugBank ID DB00760
KEGG ID D02222
MeSH ID D000077731
PubChem ID 441130
TTD Drug ID D0O5FY
NDC Product Code 44567-146; 38217-0021; 70594-075; 72572-415; 70121-1453; 44567-401; 0781-3000; 70278-104; 0409-1390; 63323-508; 63323-507; 70594-076; 70121-1454; 70278-103; 0409-1391; 68083-146; 55150-208; 72572-416; 44647-032; 44567-145; 0781-3098; 52946-0839; 44567-400; 44647-033; 55150-207; 68001-324; 0069-0314; 38217-0020; 68083-147; 68001-447; 68001-323; 68001-446
Synonyms Meropenem | 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid | Merrem | Ronem | Penem | SM 7338 | SM-7338 | SM7338
Chemical Information
Molecular Formula C17H25N3O5S
CAS Registry Number 96036-03-2
SMILES CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dermatitis bullous23.03.01.0020.000852%
Dermatitis exfoliative23.03.07.001; 10.01.01.0040.000213%
Diarrhoea07.02.01.001--
Discomfort08.01.08.0030.000319%Not Available
Disseminated intravascular coagulation24.01.01.010; 01.01.02.0020.000139%
Dizziness17.02.05.003; 02.01.02.004; 24.06.02.007--
Drug eruption10.01.01.005; 08.01.06.015; 23.03.05.0010.000319%Not Available
Drug hypersensitivity10.01.01.001--Not Available
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspepsia07.01.02.001--
Dyspnoea22.02.01.004; 02.01.03.0020.002129%
Dysuria20.02.02.002--
Electrocardiogram QT prolonged13.14.05.0040.000213%
Encephalopathy17.13.02.0010.000213%
Eosinophil count increased13.01.06.004--Not Available
Eosinophilia01.02.04.0010.001384%
Eosinophilic myocarditis02.04.03.002; 01.02.04.0070.000426%Not Available
Eosinophilic pneumonia22.01.01.004; 01.02.04.0030.000426%Not Available
Epilepsy17.12.03.0020.000745%Not Available
Epistaxis24.07.01.005; 22.04.03.001--
Erythema23.03.06.0010.001384%Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
Erythema nodosum10.02.01.020; 23.07.02.0010.000319%Not Available
Face oedema10.01.05.002; 23.04.01.004; 08.01.07.0030.000213%
Faeces discoloured07.01.03.0020.000213%Not Available
Fatigue08.01.01.002--
Febrile neutropenia08.05.02.004; 01.02.03.0020.000083%
Feeling abnormal08.01.09.014--Not Available
Feeling hot08.01.09.0090.000213%Not Available
Fixed drug eruption23.03.05.006; 10.01.01.022; 08.01.06.0170.000213%Not Available
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 11 Pages